Blue Water Vaccines, Inc.
BWVNASDAQHealthcare
$0.18
$-0.01(-6.97%)
Market Cap$3406447
P/E Ratio—
52W High$1.95
52W Low$0.1601
Blue Water Vaccines, Inc. (BWV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BWV · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$6.71
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
BWV reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 13, 2026 | — | -$6.71 | — | $0.00B | — | — |
| — Q1 FY2026 | Mar 13, 2026 | — | -$6.34 | — | $0.00B | — | — |
| ◌ Q2 FY2024 | May 12, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 14, 2024 | -$0.11 | — | — | — | — | — |
| ▼ Q4 FY2023 | Nov 17, 2023 | -$0.19 | -$0.28 | -47.4% | — | — | — |
| ▼ Q4 FY2023 | Oct 2, 2023 | -$0.12 | -$0.36 | -200.0% | — | — | — |
| ▲ Q2 FY2023 | May 12, 2023 | -$0.21 | -$0.18 | +14.3% | — | — | — |
| ▲ Q1 FY2023 | Mar 9, 2023 | -$0.25 | -$0.16 | +36.0% | — | — | — |
Q2 FY2026
May 13, 2026
EPS Actual
-$6.71
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2026
Mar 13, 2026
EPS Actual
-$6.34
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 12, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 14, 2024
EPS Actual
—
EPS Est.
-$0.11
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 17, 2023Miss
EPS Actual
-$0.28
EPS Est.
-$0.19
EPS Surpr.
-47.4%
Revenue
—
Q4 FY2023
Oct 2, 2023Miss
EPS Actual
-$0.36
EPS Est.
-$0.12
EPS Surpr.
-200.0%
Revenue
—
Q2 FY2023
May 12, 2023Beat
EPS Actual
-$0.18
EPS Est.
-$0.21
EPS Surpr.
+14.3%
Revenue
—
Q1 FY2023
Mar 9, 2023Beat
EPS Actual
-$0.16
EPS Est.
-$0.25
EPS Surpr.
+36.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.82 | $1.54 | $1.25 | 0 |
| Q2 FY2024 | $1.59 | $1.34 | $1.09 | 0 |
| Q1 FY2024 | $-0.13 | $-0.11 | $-0.09 | 0 |
| Q4 FY2023 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Q3 FY2023 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q2 FY2023 | $1.41 | $1.19 | $0.97 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 13, 2026 | — | $0.17 | — | — |
| — Q1 FY2026 | Mar 13, 2026 | — | $0.17 | — | — |
| ▼ Q4 FY2023 | Nov 17, 2023 | -47.4% | $0.30 | $0.34 | +11.77% |
| ▼ Q4 FY2023 | Oct 2, 2023 | -200.0% | $0.51 | $0.52 | +1.25% |
| ▲ Q2 FY2023 | May 12, 2023 | +14.3% | $0.99 | $1.04 | +5.05% |
| ▲ Q1 FY2023 | Mar 9, 2023 | +36.0% | $1.14 | $1.15 | +0.88% |
| ▼ Q4 FY2022 | Nov 10, 2022 | -3.9% | $0.92 | $1.07 | +16.30% |
| — Q3 FY2022 | Aug 15, 2022 | — | $2.38 | $2.44 | +2.52% |
Q2 FY2026—
Report Date
May 13, 2026
EPS Beat/Miss
—
Price Before
$0.17
Price After
—
Q1 FY2026—
Report Date
Mar 13, 2026
EPS Beat/Miss
—
Price Before
$0.17
Price After
—
Q4 FY2023+11.77%
Report Date
Nov 17, 2023
EPS Beat/Miss
-47.4%
Price Before
$0.30
Price After
$0.34
Q4 FY2023+1.25%
Report Date
Oct 2, 2023
EPS Beat/Miss
-200.0%
Price Before
$0.51
Price After
$0.52
Q2 FY2023+5.05%
Report Date
May 12, 2023
EPS Beat/Miss
+14.3%
Price Before
$0.99
Price After
$1.04
Q1 FY2023+0.88%
Report Date
Mar 9, 2023
EPS Beat/Miss
+36.0%
Price Before
$1.14
Price After
$1.15
Q4 FY2022+16.30%
Report Date
Nov 10, 2022
EPS Beat/Miss
-3.9%
Price Before
$0.92
Price After
$1.07
Q3 FY2022+2.52%
Report Date
Aug 15, 2022
EPS Beat/Miss
—
Price Before
$2.38
Price After
$2.44
Avg Beat Reaction+2.96%
Avg Miss Reaction+9.77%
Beat Rate2 / 8 quarters
Largest Move+16.30% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BWV ends December
Blue Water Vaccines, Inc. (BWV) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-6.71 (in line with the analyst consensus of —). The next BWV earnings date is expected around September 1, 2026.
Each quarter, investors track BWV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BWV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BWV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BWV earnings · 4 questionsBlue Water Vaccines, Inc.'s next earnings report is expected around September 1, 2026. BWV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BWV historically reports after market close (AMC).
BWV earnings datewhen is BWV earningsBWV next earnings datewhen does BWV report earningsBWV earnings calendar
▸ Source: FMP · Blue Water Vaccines, Inc. SEC filings · US GAAP · Blue Water Vaccines, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026